Browse by Journal Title

2020

Notch1 in cancer therapy: possible clinical implications and challenges.
Gharaibeh, L., Elmadany, N., Alwosaibai, K. and Alshaer, W.
Molecular Pharmacology 98 (5): 559-576. 1 November 2020

Kinetic analysis of the early signaling steps of the human chemokine receptor CXCR4.
Perpina-Viciano, C., Işbilir, A., Zarca, A., Caspar, B., Kilpatrick, L.E., Hill, S.J., Smit, M.J., Lohse, M.J. and Hoffmann, C.
Molecular Pharmacology 98 (2): 72-87. August 2020

2019

Context-dependent signaling of CXC chemokine receptor 4 and atypical chemokine receptor 3.
Heuninck, J., Perpina Viciano, C., Işbilir, A., Caspar, B., Capoferri, D., Briddon, S.J., Durroux, T., Hill, S.J., Lohse, M.J., Milligan, G., Pin, J.P. and Hoffmann, C.
Molecular Pharmacology 96 (6): 778-793. December 2019

2010

Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators--identification of a novel pharmacophore.
Leuner, K., Heiser, J.H., Derksen, S., Mladenov, M.I., Fehske, C.J., Schubert, R., Gollasch, M., Schneider, G., Harteneck, C., Chatterjee, S.S. and Mueller, W.E.
Molecular Pharmacology 77 (3): 368-377. March 2010

2009

The sequence after the signal peptide of the g protein-coupled endothelin B receptor is required for efficient translocon gating at the endoplasmic reticulum membrane.
Alken, M., Schmidt, A., Rutz, C., Furkert, J., Kleinau, G., Rosenthal, W. and Schuelein, R.
Molecular Pharmacology 75 (4): 801-811. April 2009

2008

Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
Schwieger, I., Lautz, K., Krause, E., Rosenthal, W., Wiesner, B. and Hermosilla, R.
Molecular Pharmacology 73 (3): 697-708. March 2008

2002

Transcriptional regulation of the rat bradykinin B2 receptor gene: Identification of a silencer element.
Baptista, H.A., Avellar, M.C.W., Araujo, R.C., Pesquero, J.L., Schanstra, J.P., Bascands, J.L., Esteve, J.P., Paiva, A.C.M., Bader, M. and Pesquero, J.B.
Molecular Pharmacology 62 (6): 1344-1355. 1 December 2002

Desensitization of homomeric alpha1 glycine receptor increases with receptor density.
Legendre, P., Muller, E., Badiu, C.I., Meier, J., Vannier, C. and Triller, A.
Molecular Pharmacology 62 (4): 817-827. October 2002

2000

From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta2-adrenoceptor antibody behave as antagonists.
Mijares, A., Lebesgue, D., Wallukat, G. and Hoebeke, J.
Molecular Pharmacology 58 (2): 373-379. 1 August 2000

Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor.
Oksche, A., Boese, G., Horstmeyer, A., Furkert, J., Beyermann, M., Bienert, M. and Rosenthal, W.
Molecular Pharmacology 57 (6): 1104-1113. June 2000

Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.
Krause, G., Hermosilla, R., Oksche, A., Rutz, C., Rosenthal, W. and Schuelein, R.
Molecular Pharmacology 57 (2): 232-242. February 2000

1998

A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.
Schuelein, R., Hermosilla, R., Oksche, A., Dehe, M., Wiesner, B., Krause, G. and Rosenthal, W.
Molecular Pharmacology 54 (3): 525-535. September 1998

1996

Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche, A., Schuelein, R., Rutz, C., Liebenhoff, U., Dickson, J., Mueller, H., Birnbaumer, M. and Rosenthal, W.
Molecular Pharmacology 50 (4): 820-828. October 1996

1994

p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
Poetsch, S., Drechsler, H., Liermann, B., Graeslund, A. and Lassmann, G.
Molecular Pharmacology 45 : 792-796. 1 January 1994